WELCOME TO

A fresh approach to Life Science PR & Marketing
Zyme Communications provides PR and marketing services for the life science sector. We support companies to raise their profile, build corporate value and generate interest from commercial leads, investors and partners.

Our
Services
Focused on supporting life science companies to raise their profile, build corporate value, and generate interest, the services we provide include:

PR & Media
- Press releases
- Article writing and placement
- Media interviews
- Messaging
- Copy writing
- Social media
- Media training
- Events

Marketing
- Conference, event and trade show support
- Marketing literature
- Market research
- Campaign development
- Advertising
- Sponsorship
- Product launches

Design & Branding
- Website design and development
- Print collateral development
- Identity and logo creation
- Brand strategy
- Presentation development
- Video production

Investor Relations
- Business plan development
- Presentation development
- PR targeting the life science trade press read by investors

The
Team
An experienced senior team of specialists in life science communications, with expertise gained in-house and agency side, offering the flexibility to support both early-stage companies and large multinationals.

EVENTS
-
Bio International
-
Milner Therapeutics Symposium 2025
-
ON Helix 2025: New Horizons for Bio Innovation
-
OBN BioTuesday
Bio-Rad Extends Anti-Idiotypic Antibody and SpyCatcher Reagent Ranges for Bioanalysis and Antibody Drug Development
Additions to Company’s Range of Bioanalytical Antibodies and Reagents Enhances Bioanalysis and Antibody-Related Research HERCULES, Calif. — June 17, 2025 — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global [...]
Sphere Bio expands operations in China
Exclusive agreement with specialist biotechnology distributor, Redbert Biotechnology, to strengthen international growth and market penetration Johnathan Fu appointed as China Distribution Manager to lead regional partnerships and enhance customer support [...]
Qureight’s synthetic study arms validate clinical efficacy in pioneering rare lung disease treatment
AI-enabled analytics platform demonstrates how real-world data used in place of human placebo and control groups can significantly reduce study costs and duration Ground-breaking data demonstrates clinical efficacy for Avalyn’s [...]